Antimetabolites and cancer: emerging data with a focus on antifolates

Author： Scagliotti Giorgio V   Selvaggi Giovanni  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.2, 2006-02, pp. : 189-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer

By Scott Sarah M   Brown Myles   Come Steven E  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 819-826

Informa Healthcare

Access to resources Recommend Favorite

Towards Species-specific Antifolates

By  

Current Medicinal Chemistry, Vol. 13, Iss. 4, 2006-02 ,pp. : 377-398

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for colorectal cancer

By Fogelman David R   Kopetz Scott   Eng Cathy  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 629-642

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for prostate cancer

By Siddiqui Kashif   Klotz Laurence H  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 455-470

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for biliary cancer

By Eckel Florian   Schmid Roland M  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 571-589

Informa Healthcare

Access to resources Recommend Favorite